Explore a one-hour webinar presented by Marc Davies, PhD and Stacie Chvatal, PhD on optimizing Chimeric Antigen Receptor (CAR) structures to enhance efficacy in solid tumors. Delve into the transition from linear to lateral architectures in CAR T-cell therapy. Learn about the revolutionary impact of second-generation CAR T-cells in treating B-cell and plasma cell malignancies, and understand the challenges faced in applying this therapy to solid tumors. Gain insights into potential strategies for improving CAR T-cell efficacy against a broader range of cancer types.
Optimizing CAR Structures to Enhance Efficacy in Solid Tumors - Moving from Linear to Lateral Architectures
Overview
Syllabus
Optimizing CAR structures to enhance efficacy in solid tumours; moving from linear to lateral...
Taught by
Labroots
Related Courses
-
Memory-Rich CAR T Cell Engineering by PiggyBac Transposon System for Solid Malignancies
-
Understanding the Mechanisms of Resistance in CAR T Immunotherapy for Lymphoma and Strategies to Overcome Them
-
Identification of Tumor-Reactive T Cell Receptors Through Functional Single Cell Interaction Analysis for Personalized T Cell Therapy
-
Multivalent RNA CAR-T Cell for Malignant Glioma
-
Monitoring of Circulating CAR T Cells
-
CAR T at UCLA - Driving the Progress of Engineered Cell Therapy
